114 related articles for article (PubMed ID: 2177148)
1. Role of ATL-derived factor (ADF) in the normal and abnormal cellular activation: involvement of dithiol related reduction.
Tagaya Y; Wakasugi H; Masutani H; Nakamura H; Iwata S; Mitsui A; Fujii S; Wakasugi N; Tursz T; Yodoi J
Mol Immunol; 1990 Dec; 27(12):1279-89. PubMed ID: 2177148
[TBL] [Abstract][Full Text] [Related]
2. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction.
Tagaya Y; Maeda Y; Mitsui A; Kondo N; Matsui H; Hamuro J; Brown N; Arai K; Yokota T; Wakasugi H
EMBO J; 1989 Mar; 8(3):757-64. PubMed ID: 2785919
[TBL] [Abstract][Full Text] [Related]
3. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.
Wakasugi N; Tagaya Y; Wakasugi H; Mitsui A; Maeda M; Yodoi J; Tursz T
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8282-6. PubMed ID: 2172979
[TBL] [Abstract][Full Text] [Related]
4. IL-2 receptor and Fc epsilon R2 gene activation in lymphocyte transformation: possible roles of ATL-derived factor.
Yodoi J; Tagaya Y; Masutani H; Maeda Y; Kawabe T
Princess Takamatsu Symp; 1988; 19():73-86. PubMed ID: 2978620
[TBL] [Abstract][Full Text] [Related]
5. IL-2 receptor(p55)/Tac-inducing factor. Purification and characterization of adult T cell leukemia-derived factor.
Tagaya Y; Okada M; Sugie K; Kasahara T; Kondo N; Hamuro J; Matsushima K; Dinarello CA; Yodoi J
J Immunol; 1988 Apr; 140(8):2614-20. PubMed ID: 2895791
[TBL] [Abstract][Full Text] [Related]
6. ADF (adult T cell leukemia-derived factor)/human thioredoxin and viral infection: possible new therapeutic approach.
Masutani H; Nakamura H; Ueda Y; Kitaoka Y; Kawabe T; Iwata S; Mitsui A; Yodoi J
Adv Exp Med Biol; 1992; 319():265-74. PubMed ID: 1329444
[TBL] [Abstract][Full Text] [Related]
7. Adult T-cell leukaemia-derived factor/thioredoxin expression on the HTLV-I transformed T-cell lines: heterogeneous expression in ALT-2 cells.
Makino S; Masutani H; Maekawa N; Konishi I; Fujii S; Yamamoto R; Yodoi J
Immunology; 1992 Aug; 76(4):578-83. PubMed ID: 1398748
[TBL] [Abstract][Full Text] [Related]
8. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression.
Teshigawara K; Maeda M; Nishino K; Nikaido T; Uchiyama T; Tsudo M; Wano Y; Yodoi J
J Mol Cell Immunol; 1985; 2(1):17-26. PubMed ID: 2978223
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte transformation and thiol compounds; the role of ADF/thioredoxin as an endogenous reducing agent.
Yamauchi A; Masutani H; Tagaya Y; Wakasugi N; Mitsui A; Nakamura H; Inamoto T; Ozawa K; Yodoi J
Mol Immunol; 1992 Feb; 29(2):263-70. PubMed ID: 1542302
[TBL] [Abstract][Full Text] [Related]
10. Redox control of Epstein-Barr virus replication by human thioredoxin/ATL-derived factor: differential regulation of lytic and latent infection.
Sono H; Teshigawara K; Sasada T; Takagi Y; Nishiyama A; Ohkubo Y; Maeda Y; Tatsumi E; Kanamaru A; Yodoi J
Antioxid Redox Signal; 1999; 1(2):155-65. PubMed ID: 11228744
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors.
U-Taniguchi Y; Furuke K; Masutani H; Nakamura H; Yodoi J
Oncol Res; 1995; 7(3-4):183-9. PubMed ID: 8555652
[TBL] [Abstract][Full Text] [Related]
12. Detection of adult T-cell leukemia-derived factor/human thioredoxin in human serum.
Kitaoka Y; Sorachi K; Nakamura H; Masutani H; Mitsui A; Kobayashi F; Mori T; Yodoi J
Immunol Lett; 1994 Jul; 41(2-3):155-61. PubMed ID: 8002031
[TBL] [Abstract][Full Text] [Related]
13. TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines.
Okada M; Maeda M; Tagaya Y; Taniguchi Y; Teshigawara K; Yoshiki T; Diamantstein T; Smith KA; Uchiyama T; Honjo T
J Immunol; 1985 Dec; 135(6):3995-4003. PubMed ID: 2999237
[TBL] [Abstract][Full Text] [Related]
14. Redox regulation of cellular activation.
Nakamura H; Nakamura K; Yodoi J
Annu Rev Immunol; 1997; 15():351-69. PubMed ID: 9143692
[TBL] [Abstract][Full Text] [Related]
15. Expression and co-cytokine function of murine thioredoxin/adult T cell leukaemia-derived factor (ADF).
Blum H; Röllinghoff M; Gessner A
Cytokine; 1996 Jan; 8(1):6-13. PubMed ID: 8742061
[TBL] [Abstract][Full Text] [Related]
16. [Measurement of ADF/thioredoxin in human serum and its clinical significance].
Kitaoka Y; Sachi Y; Mori T; Yodoi J
Rinsho Byori; 1994 Aug; 42(8):853-9. PubMed ID: 7933622
[TBL] [Abstract][Full Text] [Related]
17. Expression and growth-promoting effect of adult T-cell leukemia-derived factor. A human thioredoxin homologue in hepatocellular carcinoma.
Nakamura H; Masutani H; Tagaya Y; Yamauchi A; Inamoto T; Nanbu Y; Fujii S; Ozawa K; Yodoi J
Cancer; 1992 Apr; 69(8):2091-7. PubMed ID: 1311982
[TBL] [Abstract][Full Text] [Related]
18. ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin: involvement in lymphocyte immortalization by HTLV-I and EBV.
Yodoi J; Tursz T
Adv Cancer Res; 1991; 57():381-411. PubMed ID: 1659124
[No Abstract] [Full Text] [Related]
19. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction.
Tagaya Y; Maeda Y; Mitsui A; Kondo N; Matsui H; Hamuro J; Brown N; Arai K; Yokota T; Wakasugi H
EMBO J; 1994 May; 13(9):2244. PubMed ID: 8187776
[No Abstract] [Full Text] [Related]
20. Thiol-mediated redox regulation of lymphocyte proliferation. Possible involvement of adult T cell leukemia-derived factor and glutathione in transferrin receptor expression.
Iwata S; Hori T; Sato N; Ueda-Taniguchi Y; Yamabe T; Nakamura H; Masutani H; Yodoi J
J Immunol; 1994 Jun; 152(12):5633-42. PubMed ID: 8207197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
